{"id":6282,"date":"2025-02-25T13:48:54","date_gmt":"2025-02-25T13:48:54","guid":{"rendered":"https:\/\/splmed.com\/?p=6282"},"modified":"2025-02-25T13:48:54","modified_gmt":"2025-02-25T13:48:54","slug":"ferumoxtran-the-iron-based-investigational-mri-contrast-agent-of-spl-medical-b-v-meets-primary-endpoints-in-pivotal-phase-iii-study","status":"publish","type":"post","link":"https:\/\/splmed.com\/english\/ferumoxtran-the-iron-based-investigational-mri-contrast-agent-of-spl-medical-b-v-meets-primary-endpoints-in-pivotal-phase-iii-study\/","title":{"rendered":"Ferumoxtran, the iron-based investigational MRI contrast agent of SPL Medical B.V., meets primary endpoints in pivotal Phase III study."},"content":{"rendered":"<p class=\"p2\">SPL Medical B.V. announced today the headline results of the pivotal phase III study PROSTAPROGRESS (EudraCT 2018-004310-18), aiming to assess the diagnostic accuracy of Ferumoxtran enhanced Magnetic Resonance Imaging (MRI) for lymph node detection in prostate cancer patients.<\/p>","protected":false},"excerpt":{"rendered":"<p>SPL Medical B.V. announced today the headline results of the pivotal phase III study PROSTAPROGRESS (EudraCT 2018-004310-18), aiming to assess the diagnostic accuracy of Ferumoxtran enhanced Magnetic Resonance Imaging (MRI) for lymph node detection in prostate cancer patients.<\/p>","protected":false},"author":2,"featured_media":5922,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[22],"tags":[],"class_list":["post-6282","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-release"],"_links":{"self":[{"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/posts\/6282","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/comments?post=6282"}],"version-history":[{"count":1,"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/posts\/6282\/revisions"}],"predecessor-version":[{"id":6283,"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/posts\/6282\/revisions\/6283"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/media\/5922"}],"wp:attachment":[{"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/media?parent=6282"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/categories?post=6282"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/tags?post=6282"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}